Archived News for Health Sector Professionals - May, 2019
New cancer targets emerge
Australian research has identified two new potential therapies for childhood and common cancers.
QUT takes on concussion study
The US Department of Defence is funding a concussion study in Queensland.
Tasmanian EDs slammed
Tasmania's health system is severely compromising patient safety, the state's auditor-general says.
AMA warns of US drift
The president of the AMA says Australia’s health system is becoming concerningly similar to the United States'.
Ambulance survey concerning
Research has revealed a lack of public understanding about when to call an ambulance.
New embyro test available
A revolutionary new non-invasive embryo screening test could reduce miscarriages.
Screen time sleep loss studied
Research suggests teens' sleep patterns can be improved by reducing blue light exposure ...
Drug swab accuracy questioned
A NSW court ruling has called the accuracy of roadside drug tests into question.
Genes compressed in lab-born life
Researchers have found a way to compress the genetic code of synthetic organisms.
Single shot for deadly diseases
Local experts have come up with a single vaccine to simultaneously combat two of the world’s most deadly respiratory diseases.
Experts concerned over aged changes
The uncoupling of healthcare from aged care could have worrying results, experts say.
HBV checks suggested
Australian experts say all patients undergoing cancer treatment should be tested for hepatitis B virus (HBV).
Health pledges should be kept
The newly-returned Morrison Government should be held to account for massive health promises.
New clinic for high school help
Australian experts have set up Australia’s first psychology outreach clinic for high school students.
More Roundup cancer compo
A US jury has ordered Monsanto to pay $US2 billion ($2.8b) to a couple who contracted cancer after using the commonly used weedkiller, Roundup.
Mental health genes revealed
Local researchers have identified 70 previously unknown genes that contribute to people developing serious mental health disorders.
ACCC allows big drug deal
The competition regulator has allowed GSK’s proposed acquisition of Pfizer’s consumer healthcare business in Australia to continue.